Mereo Biopharma Group PLC
NASDAQ:MREO

Watchlist Manager
Mereo Biopharma Group PLC Logo
Mereo Biopharma Group PLC
NASDAQ:MREO
Watchlist
Price: 3.2 USD -2.14% Market Closed
Updated: May 19, 2024

Mereo Biopharma Group PLC
Total Current Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Mereo Biopharma Group PLC
Total Current Assets Peer Comparison

Comparables:
CNTA
AUTL
BCYC
IMCR
GNS

Competitive Total Current Assets Analysis
Latest Figures & CAGR of Competitors

Company Total Current Assets CAGR 3Y CAGR 5Y CAGR 10Y
Mereo Biopharma Group PLC
NASDAQ:MREO
Total Current Assets
£62.1m
CAGR 3-Years
27%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Centessa Pharmaceuticals PLC
NASDAQ:CNTA
Total Current Assets
$315.1m
CAGR 3-Years
204%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Autolus Therapeutics PLC
NASDAQ:AUTL
Total Current Assets
$275.3m
CAGR 3-Years
12%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
Bicycle Therapeutics PLC
NASDAQ:BCYC
Total Current Assets
$516m
CAGR 3-Years
34%
CAGR 5-Years
49%
CAGR 10-Years
N/A
Immunocore Holdings PLC
NASDAQ:IMCR
Total Current Assets
£528.8m
CAGR 3-Years
51%
CAGR 5-Years
25%
CAGR 10-Years
N/A
Genus PLC
LSE:GNS
Total Current Assets
£277.4m
CAGR 3-Years
7%
CAGR 5-Years
8%
CAGR 10-Years
5%

See Also

What is Mereo Biopharma Group PLC's Total Current Assets?
Total Current Assets
62.1m GBP

Based on the financial report for Dec 31, 2022, Mereo Biopharma Group PLC's Total Current Assets amounts to 62.1m GBP.

What is Mereo Biopharma Group PLC's Total Current Assets growth rate?
Total Current Assets CAGR 3Y
27%

Over the last year, the Total Current Assets growth was -37%. The average annual Total Current Assets growth rates for Mereo Biopharma Group PLC have been 27% over the past three years .